Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 44,645 | 38,441 | 39,766 | 37,153 | 39,224 |
| Cost of Goods | 28,079 | 22,540 | 25,082 | 38,524 | 29,166 |
| Gross Profit | 16,566 | 15,901 | 14,684 | -1,371 | 10,058 |
| Operating Expenses | 57,842 | 55,318 | 59,619 | 428,087 | 163,252 |
| Operating Income | -41,197 | -38,877 | -44,853 | -428,934 | -153,028 |
| Interest Expense | 1,740 | 1,739 | 1,738 | 1,737 | 2,757 |
| Other Income | 2,768 | 2,999 | 4,696 | 4,294 | 158,472 |
| Pre-tax Income | -40,169 | -37,617 | -41,895 | -426,377 | 2,687 |
| Income Tax | 202 | 383 | 35 | -302 | N/A |
| Net Income Continuous | -40,371 | -38,000 | -41,930 | -426,075 | 2,371 |
| Net Income | $-40,371 | $-38,000 | $-41,930 | $-426,075 | $2,371 |
| EPS Basic Total Ops | -0.11 | -0.13 | -0.14 | -1.44 | 0.02 |
| EPS Basic Continuous Ops | -0.12 | -0.13 | -0.14 | -1.44 | 0.02 |
| EPS Diluted Total Ops | -0.11 | -0.13 | -0.14 | -1.44 | -0.44 |
| EPS Diluted Continuous Ops | -0.12 | -0.13 | -0.14 | -1.44 | 0.07 |
| EPS Diluted Before Non-Recurring Items | -0.12 | -0.12 | -0.13 | -0.15 | -0.20 |
| EBITDA(a) | $-37,008 | $-35,398 | $-41,547 | $-42,861 | $-53,160 |